Comparative Study of 3-Dimensional-Printed Poly-L-Lactic Acid/Bone Morphogenetic Protein (BMP)/Collagen Bone Substitute and Commercial Hydroxyapatite/BMP for Bone Regeneration Efficacy Using a Mouse Calvarial Model
Clinics in Orthopedic Surgery · 2025
DOI: 10.4055/cios24323 ↗At a glance
Vergleichsstudie in Clinics in Orthopedic Surgery, 2025. Written by Tae Ho Kim and 3 co-authors. Institution: Bio-Medical Research Institute, Kyungpook National University Hospital, Daegu, Korea. Major MEDLINE topics: Bone Regeneration, Polyesters, Bone Morphogenetic Protein 2, Durapatite. 12 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Korean Fund for Regenerative Medicine.
Abstract (original language)
Background
Bone substitutes such as hydroxyapatite (HA) ceramic and recombinant bone morphogenetic protein-2 (BMP-2) are essential in treating bone defects. However, the challenges of controlled and localized BMP-2 delivery necessitate the development of advanced bone graft substitutes. This study introduces and evaluates an innovative, ready-to-use bone substitute employing 3-dimensional-printed poly-L-lactic acid (PLLA) scaffolds combined with BMP-2 to enhance bone regeneration efficiency.
Methods
We conducted a comparative study using C57BL/6 mice to evaluate the efficacy of rhBMP-2-coated PLLA scaffolds against traditional HA-based bone graft materials. The PLLA scaffolds were coated with varying concentrations of BMP-2 using an alginate-catechol method. Bone regeneration was assessed through micro-computed tomography (CT) imaging and histological analysis 4 weeks after implantation. The statistical significance of bone mass and formation differences across groups was determined using Student t-test and analysis of variance.
Results
Micro-CT analysis revealed substantial bone formation in the group with PLLA scaffolds containing 0.1% BMP-2, exhibiting a bone volume ratio of 11.1% ± 2.8%, significantly higher than all other groups (p = 0.008). Histological analysis corroborated these findings, showing dense collagen deposition and active osteoblast presence in this group, indicating enhanced bone regeneration.
Conclusions
The novel PLLA scaffold with alginate-catechol-coated BMP-2 significantly enhances bone regeneration compared to traditional bone graft materials. This innovative approach holds promising potential for clinical applications in orthopedics, particularly for treating bone defects.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Bio-Medical Research Institute, Kyungpook National University Hospital, Daegu, Korea.
- Joint Institute for Regenerative Medicine, Kyungpook National University, Daegu, Korea.
- School of Medicine, Kyungpook National University, Daegu, Korea.
- Department of Orthopedic Surgery, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Korea.
ORCID profiles: Tae Ho Kim, Yu Ri Hong, Jeong Ok Lim, Chang-Wug Oh
Funding
- Korean Fund for Regenerative Medicine
Cite
APA
Kim, T. H., Hong, Y. R., Lim, J. O., & Oh, C. W. (2025). Comparative Study of 3-Dimensional-Printed Poly-L-Lactic Acid/Bone Morphogenetic Protein (BMP)/Collagen Bone Substitute and Commercial Hydroxyapatite/BMP for Bone Regeneration Efficacy Using a Mouse Calvarial Model. Clinics in Orthopedic Surgery. https://doi.org/10.4055/cios24323
Vancouver
Kim TH, Hong YR, Lim JO, Oh CW. Comparative Study of 3-Dimensional-Printed Poly-L-Lactic Acid/Bone Morphogenetic Protein (BMP)/Collagen Bone Substitute and Commercial Hydroxyapatite/BMP for Bone Regeneration Efficacy Using a Mouse Calvarial Model. Clinics in Orthopedic Surgery. 2025. doi:10.4055/cios24323
BibTeX
@article{Kim2025,
author = {Kim, Tae Ho and Hong, Yu Ri and Lim, Jeong Ok and Oh, Chang-Wug},
title = {Comparative Study of 3-Dimensional-Printed Poly-L-Lactic Acid/Bone Morphogenetic Protein (BMP)/Collagen Bone Substitute and Commercial Hydroxyapatite/BMP for Bone Regeneration Efficacy Using a Mouse Calvarial Model},
journal = {Clinics in Orthopedic Surgery},
year = {2025},
doi = {10.4055/cios24323}
}
EUVIMED